Parkinson Disease Clinical Trials in Houston, Texas
5 studies are recruiting for parkinson disease in Houston, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
The goal of this Phase 2 clinical trial is to investigate the efficacy and safety of NEU-411 in men and women aged 40-80 years with early Parkinson's Disease (PD) who have predicted elevations in the activity of the "leucine-rich repeat kinase 2" ("LRRK2" for short) pathway based on their genetic p…
- Stage
- Phase 2
- Ages
- 40 to 80
- Site
- Baylor College of Medicine, Houston, Texas
- Locations
- 72 in total
- Run by
- Neuron23 Inc.
-
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
The Parkinson Progression Marker Initiative (PPMI) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features, digital outcomes, and imaging, biologic and genetic markers of Parkinson's disease (PD) progression in study participants with manifest…
- Stage
- Not phased
- Ages
- 30 and older
- Site
- Baylor College of Medicine, Houston, Texas
- Locations
- 50 in total
- Run by
- Michael J. Fox Foundation for Parkinson's Research
-
A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
The objective of this randomized, surgically controlled, double-blinded, Phase 2 study is to evaluate the safety and efficacy of AAV2-GDNF delivered to the putamen in subjects with moderate Parkinson's Disease.
- Stage
- Phase 2
- Ages
- 45 to 75
- Site
- Houston Methodist (Neurology), Houston, Texas
- Locations
- 46 in total
- Run by
- AskBio Inc
-
Black and African Americans Connections to Parkinson's Disease (BLAAC PD)
BLAAC PD is a research study to understand what Parkinson's disease looks like for Black and African American communities. BLAAC PD is happening at research centers around the United States. The study is part of the Global Parkinson's Genetics Program (GP2). GP2 is a research project working to tra…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of Texas Health Science Center, Houston, Houston, Texas
- Locations
- 12 in total
- Run by
- Michael J. Fox Foundation for Parkinson's Research
-
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
The primary purpose of this study is to evaluate efficacy and safety of CREXONT under real world conditions in participants with Parkinson disease (PD).
- Stage
- Phase 4
- Ages
- 18 and older
- Site
- The University of Texas Health Science Center at Houston- McGovern Medical School, Houston, Texas
- Locations
- 27 in total
- Run by
- Impax Laboratories, LLC
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.